Japanese health food company acquires Daiya Foods
Tokyo-headquartered Otsuka Pharmaceutical says that after the $325m deal is finalized, the plant-based cheese alternative supplier will become a pillar of its nutraceuticals business.
Tokyo-headquartered Otsuka Pharmaceutical says that after the $325m deal is finalized, the plant-based cheese alternative supplier will become a pillar of its nutraceuticals business.
Copyright PEI Media
Not for publication, email or dissemination